You are here

BioMark Diagnostics Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
BUX
CSE Index: 
Currency: 

BioMark is a Canadian based company that is developing its advanced stage cancer diagnostic business. BioMark’s cancer diagnostics technology has developed to date into a metabolomics-based diagnostic assay that allows for early cancer detection. BioMark is currently focused on bringing its cancer diagnostic kits and detection system up to commercialization standards and hopes to commence distribution once clinical trials are complete and regulatory acceptance is obtained. For more information please visit the company’s website at www.biomarkdiagnostics.com

You are here

BioMark Diagnostics Inc. (BUX)

SEDAR Information

Company Info

Address
165-10551 Shellbridge Way
Richmond, BC V6X 2W8
Canada
Phone
604-370-0779
Fax
--
Email
info@biomarkdiagnostics.com
Website
http://www.biomarkdiagnostics.com
Listing date
Monday, November 3, 2014
Transfer Agent
Computershare Investor Services Inc.
Investor Relations
Rashid Bux
Auditor
Manning Elliott LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
65,015,119
Reserved for Issuance: 
10,682,339

Bulletins

31/10/2014

2014-1017 - New Listing – BioMark Diagnostics Inc. (BUX)

New Listing - BioMark Diagnostics Inc.

Advertisement

Publicité

Latest CSE News

Upcoming Events

01_20_VRIC_2019_Website

Vancouver Resource Investment Conference - VRIC 2019

Sunday, January 20, 2019 (All day) to Monday, January 21, 2019 (All day)
01_22_Canada_Cannabis_House_Website_v5

Canada Cannabis House at Davos

Tuesday, January 22, 2019 (All day) to Thursday, January 24, 2019 (All day)
01_22_Regional_Investments_Cap_Markets_Conf_2019_Website

Regional Investments & Capital Markets Conference 2019

Tuesday, January 22, 2019 (All day) to Thursday, January 24, 2019 (All day)